• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD4(+) /CD8(+) T 细胞计数对儿童异基因造血干细胞移植后急性移植物抗宿主病发生的影响及 NK 细胞计数对结局的影响。

Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.

机构信息

Division of Hematology-Oncology and Stem Cell Transplantation, Children's Hospital, Helsinki University Central Hospital, Helsinki, Finland.

出版信息

Pediatr Blood Cancer. 2015 Mar;62(3):522-8. doi: 10.1002/pbc.25347. Epub 2014 Nov 21.

DOI:10.1002/pbc.25347
PMID:25417898
Abstract

BACKGROUND

Increasing evidence suggests that early and rapid lymphocyte recovery following allogeneic hematopoietic stem cell transplantation (HSCT) is associated with better survival.

PROCEDURE

We retrospectively analyzed very early lymphocyte subset counts following transplantation from our 5-year pediatric allogeneic HSCT material to find clinically relevant associations with post transplant outcome, and the major complication of HSCT, acute graft-versus-host disease (aGVHD). We analyzed HSCTs performed due to acute leukemias and lymphomas from matched unrelated donors (MUD, n = 33), unrelated cord blood (UCB, n = 9) and matched sibling donors (MSD, n = 17).

RESULTS

Patients with grafts from MUDs and grade II-IV aGVHD) had higher (median 2.1 compared to 0.3, P<0.0001) and earlier (at day +18 post transplant vs. day +25, P = 0.004) first measurable CD4(+) /CD8(+) T cell ratio, compared to patients with no or grade I aGVHD, respectively. At day +32 after HSCT patients with MUDs and significant aGVHD had higher levels of both CD4(+) and CD8(+) T cell subsets. Low (below median 120/µL) versus high natural killer (NK) cell counts at day +32 were associated with 3-year event-free survival of 27.4 +/- 9.0% versus 82.4 +/- 6.4% (P < 0.0001), cumulative transplant-related mortality of 44.7 +/- 12.2% versus 3.0 +/- 3.0% (P < 0.001) and cumulative relapse incidence of 50.4 +/- 12.2% versus 15.0 +/- 6.2% (P = 0.019), respectively.

CONCLUSIONS

We conclude that early lymphocyte subset counts following allogeneic HSCT have an association with aGVHD and post transplant outcome.

摘要

背景

越来越多的证据表明,异基因造血干细胞移植(HSCT)后早期和快速的淋巴细胞恢复与更好的生存相关。

方法

我们回顾性分析了来自我们 5 年儿科异基因 HSCT 资料的移植后非常早期的淋巴细胞亚群计数,以找到与移植后结果和 HSCT 的主要并发症——急性移植物抗宿主病(aGVHD)相关的临床相关关联。我们分析了来自非亲缘供体(MUD,n=33)、无关脐带血(UCB,n=9)和匹配同胞供体(MSD,n=17)的急性白血病和淋巴瘤患者的 HSCT。

结果

MUD 供体和 II-IV 级 aGVHD 患者的(中位数为 2.1 比 0.3,P<0.0001)和更早(移植后第 18 天 vs. 第 25 天,P=0.004)可测量的 CD4+/CD8+T 细胞比值更高,与无或 I 级 aGVHD 患者相比。在 HSCT 后第 32 天,MUD 供体和明显 aGVHD 患者的 CD4+和 CD8+T 细胞亚群水平更高。第 32 天自然杀伤(NK)细胞计数低(低于中位数 120/µL)与 3 年无事件生存率 27.4+/-9.0%与 82.4+/-6.4%(P<0.0001)、累计移植相关死亡率 44.7+/-12.2%与 3.0+/-3.0%(P<0.001)和累计复发率 50.4+/-12.2%与 15.0+/-6.2%(P=0.019)相关。

结论

我们得出结论,异基因 HSCT 后早期淋巴细胞亚群计数与 aGVHD 和移植后结果相关。

相似文献

1
Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.CD4(+) /CD8(+) T 细胞计数对儿童异基因造血干细胞移植后急性移植物抗宿主病发生的影响及 NK 细胞计数对结局的影响。
Pediatr Blood Cancer. 2015 Mar;62(3):522-8. doi: 10.1002/pbc.25347. Epub 2014 Nov 21.
2
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.T 细胞剂量对 HLA 匹配的异基因外周血造血干细胞移植后 T 细胞重建结局的影响。
Biol Blood Marrow Transplant. 2019 Sep;25(9):1875-1883. doi: 10.1016/j.bbmt.2019.05.007. Epub 2019 May 11.
3
Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation.无关供者脐血移植后100天内免疫重建及循环血清炎症介质/细胞因子与急性移植物抗宿主病发生率的相关性
Bone Marrow Transplant. 1999 Sep;24(5):535-44. doi: 10.1038/sj.bmt.1701921.
4
T cell reconstitution in allogeneic haematopoietic stem cell transplantation: prognostic significance of plasma interleukin-7.异基因造血干细胞移植中的T细胞重建:血浆白细胞介素-7的预后意义
Scand J Immunol. 2015 Jan;81(1):72-80. doi: 10.1111/sji.12244.
5
Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.移植后自然杀伤细胞计数:异基因造血干细胞移植后急性移植物抗宿主病和生存结局的预测指标
Clin Lymphoma Myeloma Leuk. 2016 Sep;16(9):527-535.e2. doi: 10.1016/j.clml.2016.06.013. Epub 2016 Jun 8.
6
Graft-versus-leukemia effect in hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia: significantly lower relapse rate in unrelated transplantations.儿童急性淋巴细胞白血病造血干细胞移植中的移植物抗白血病效应:无关供者移植的复发率显著降低。
Bone Marrow Transplant. 2007 Nov;40(10):951-5. doi: 10.1038/sj.bmt.1705853. Epub 2007 Sep 17.
7
Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.移植后浆细胞样树突状细胞数量低与异基因干细胞移植后早期高死亡率相关。
Biol Blood Marrow Transplant. 2015 Jul;21(7):1223-9. doi: 10.1016/j.bbmt.2015.03.010. Epub 2015 Mar 17.
8
Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.异基因造血干细胞移植后绝对淋巴细胞计数的恢复可预测临床结局。
Biol Blood Marrow Transplant. 2015 May;21(5):873-80. doi: 10.1016/j.bbmt.2015.01.019. Epub 2015 Jan 23.
9
Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation.在严重获得性再生障碍性贫血的儿童中,匹配同胞与匹配无关供者异基因造血干细胞移植的比较:波兰造血干细胞移植儿科组的经验。
Arch Immunol Ther Exp (Warsz). 2012 Jun;60(3):225-33. doi: 10.1007/s00005-012-0174-1. Epub 2012 Apr 17.
10
Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease-Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed Acute Leukemia.在难治/复发性急性白血病患者中,进行异基因造血干细胞移植后,采用预防供者淋巴细胞输注(DLI),随后进行微小残留病和移植物抗宿主病指导的多次 DLI,可改善预后。
Biol Blood Marrow Transplant. 2017 Aug;23(8):1311-1319. doi: 10.1016/j.bbmt.2017.04.028. Epub 2017 May 5.

引用本文的文献

1
High NK cell counts at day 90 predict improved survival in event-free patients after T-cell depleted allogeneic stem cell transplantation.第90天时自然杀伤细胞计数高预示着T细胞去除的异基因干细胞移植后无事件患者的生存率提高。
Front Immunol. 2025 Jun 18;16:1577924. doi: 10.3389/fimmu.2025.1577924. eCollection 2025.
2
Immune Monitoring after Cell Therapy and Hematopoietic Cell Transplantation: Guidelines by the ISCT Stem Cell Engineering Committee.细胞治疗和造血细胞移植后的免疫监测:国际细胞治疗协会干细胞工程委员会指南
Cytotherapy. 2025 May 5. doi: 10.1016/j.jcyt.2025.04.069.
3
Using T-lymphocyte subsets at engraftment to predict the risk of acute graft-versus-host disease in patients with thalassemia major: development of a new predictive nomogram.
利用植入时的T淋巴细胞亚群预测重型地中海贫血患者急性移植物抗宿主病的风险:一种新的预测列线图的开发。
Ther Adv Hematol. 2024 Dec 10;15:20406207241294054. doi: 10.1177/20406207241294054. eCollection 2024.
4
Prognostic significance of early nk cell recovery in pediatric t-cell replete allogeneic hematopoietic stem cell transplantation.儿童T细胞充足的异基因造血干细胞移植中早期NK细胞恢复的预后意义
Ann Hematol. 2024 Dec;103(12):5769-5780. doi: 10.1007/s00277-024-06084-1. Epub 2024 Nov 16.
5
Kinetics of Recovery of Naïve and Memory T Cells in Acute Leukemia Patients after Allogeneic Stem Cell Transplantation Depending on Different GVHD Prophylaxis Regimens.异基因干细胞移植后,急性白血病患者中初始T细胞和记忆T细胞的恢复动力学取决于不同的移植物抗宿主病预防方案。
Int J Hematol Oncol Stem Cell Res. 2024 Jan 1;18(1):33-46. doi: 10.18502/ijhoscr.v18i1.14742.
6
Exosomes derived from bone marrow mesenchymal stem cells alleviate biliary ischemia reperfusion injury in fatty liver transplantation by inhibiting ferroptosis.骨髓间充质干细胞来源的外泌体通过抑制铁死亡缓解脂肪肝移植中的胆系缺血再灌注损伤。
Mol Cell Biochem. 2024 Apr;479(4):881-894. doi: 10.1007/s11010-023-04770-8. Epub 2023 May 27.
7
CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植5年后的巨细胞病毒血清学状态与T细胞受体谱多样性
Leukemia. 2023 Apr;37(4):948-951. doi: 10.1038/s41375-023-01836-w. Epub 2023 Feb 16.
8
Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation.血细胞计数在慢性髓系肿瘤和急性髓系白血病中的预后作用及其在造血干细胞移植中的潜在意义
Diagnostics (Basel). 2022 Oct 14;12(10):2493. doi: 10.3390/diagnostics12102493.
9
Activated CD4 + T lymphocyte is a potential biomarker for acute graft-vs.-host disease after hematopoietic stem cell transplantation in children with transfusion-dependent β-thalassemia.活化的CD4 + T淋巴细胞是输血依赖型β地中海贫血患儿造血干细胞移植后急性移植物抗宿主病的潜在生物标志物。
Front Pediatr. 2022 Sep 29;10:985306. doi: 10.3389/fped.2022.985306. eCollection 2022.
10
Insights into mechanisms of graft-versus-host disease through humanised mouse models.通过人源化小鼠模型深入了解移植物抗宿主病的机制。
Biosci Rep. 2022 Sep 30;42(9). doi: 10.1042/BSR20211986.